Overview

Sleep Quality and Amyloid-Beta Kinetics

Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to change the concentration of amyloid-beta in human cerebrospinal fluid (CSF) by modification of sleep efficiency.
Phase:
N/A
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Suvorexant